Frequently Asked Questions

Ovulation Induction is a process that stimulates the ovaries to produce more eggs, typically through the use of fertility medications. It is recommended when natural ovulation is irregular or when multiple eggs are desired for assisted reproductive techniques like IVF.

Common methods include transvaginal ultrasounds to measure follicle size and number and blood tests to assess hormone levels, including estradiol and luteinizing hormone (LH).

Follicular Tests, which include ultrasound scans and blood tests, help evaluate the development of ovarian follicles and determine when they are mature for ovulation. It is a tool to track the growth of the follicle if in case hampered in certain conditions, additional medications can be given to ensure a good follicular growth which inturn translates to a healthy egg. This information is crucial for timing procedures like IUI and IVF.

Natural Cycle Monitoring involves observing a woman's menstrual cycle without the use of medications to stimulate or regulate it. It is a more natural approach, useful for couples seeking to conceive without the use of fertility medications.

Cycle Monitoring is a critical aspect of fertility treatment that involves tracking a woman's menstrual cycle and reproductive hormone levels to optimize the timing of procedures like intrauterine insemination (IUI) or in vitro fertilization (IVF). It ensures that fertility treatments are conducted at the most opportune moments.

The main difference between frozen and fresh embryo transfer lies in the timing of the embryo transfer. In fresh embryo transfer, embryos are transferred to the woman's uterus in the same cycle as ovarian stimulation and egg retrieval, while in frozen embryo transfer, embryos are cryopreserved and transferred in a subsequent cycle. This allows for better timing and preparation, potentially reducing the risk of ovarian hyperstimulation syndrome (OHSS) and providing flexibility in scheduling. Success rates for frozen embryo transfer are often comparable to or slightly better than those for fresh transfer, and it may offer the advantage of multiple opportunities for pregnancy from a single IVF cycle. Additionally, frozen transfer can be used for embryo selection through preimplantation genetic testing (PGT), which may further improve outcomes.

The success rate of frozen embryo transfer (FET) varies based on multiple factors, including the woman's age, embryo quality, and the underlying cause of infertility. In general, for women under 35 with good-quality embryos, FET success rates range from 30% to 60% per embryo transfer, which is often comparable to or slightly better than fresh embryo transfer outcomes. Success rates decline with increasing age. It's important to consider that success can require multiple FET cycles. Personalized assessments by fertility specialists and the use of preimplantation genetic testing (PGT) for embryo selection can further enhance the likelihood of a successful FET.

OHSS, or Ovarian Hyperstimulation Syndrome, is a medical condition that can occur in women undergoing fertility treatments, particularly in vitro fertilization (IVF) and ovarian stimulation. It results from the ovaries becoming excessively enlarged and filled with fluid, leading to various symptoms and potential complications.

The entire process can take several weeks to a few months, including pre-IVF preparation, treatment cycles, and pregnancy testing. The duration can vary depending on individual circumstances and the chosen protocol.

Potential risks may include multiple pregnancies, side effects from fertility medications, and discomfort during procedures. Discuss these risks with a healthcare provider.